Ayahuasca in the treatment of bipolar disorder with psychotic features-A retrospective case study
This retrospective case study describes a woman with bipolar disorder and psychotic features whose suicidality, dissociation and social isolation markedly improved and were sustained after multiple ayahuasca ceremonies, with corroboration of childhood abuse and ongoing symptom reduction over several years. The report suggests potential therapeutic benefits of ayahuasca for severe traumatisation and bipolar symptoms and situates the case within a brief review of low‑dose ayahuasca and LSD treatment literature.
Abstract
Ayahuasca is a plant-based brew of indigenous Amazonian origin. It has psychedelic, anti-inflammatory, neuroprotective, cytotoxic, and anti-parasitic effects, which are primarily due to monoamine oxidase inhibitors (MAOIs) and N,N-dimethyltryptamine (DMT). This article describes the case of a woman in her late thirties with complex trauma due to severe, years-long sexual abuse in early childhood, resulting in a decades-long chronic condition involving suicidality. She was diagnosed with bipolar disorder and borderline personality disorder, but refused to accept either of them. She presented with delusional parasitosis and deep dissociation. Despite being severely psychotic in private, she appeared high-functioning in public, hiding most of her symptoms. In her mid-thirties, she participated in an ayahuasca ceremony in a legal setting. It resolved her suicidality, eliminated her social isolation, and reduced her shame related to her early trauma. Nine more ceremonies alleviated her distress further. Her abuser also participated in an ayahuasca ceremony and confirmed her memories of childhood abuse. The first interview was conducted 1.5 years after her first ceremony, and a follow-up interview 2.5 years later. She had experienced sixteen additional ceremonies, recognized the validity of her bipolar disorder diagnosis, and believed her early trauma to be its sole cause. Her core trauma remained partially unresolved, but her dissociative symptoms continued to decrease. She had observed several other instances of psychosis and bipolar disorder in which ayahuasca had resulted in positive effects. This case study contributes to a better understanding of the use of ayahuasca in bipolar disorder and severe traumatization. It also reviews the current state-of-the-art in the treatment of bipolar disorder using low-dose ayahuasca, and a case in which bipolar disorder was resolved with LSD.
Research Summary of 'Ayahuasca in the treatment of bipolar disorder with psychotic features-A retrospective case study'
Introduction
Earlier research and clinical reporting on the use of classical psychedelics in people with psychoses or bipolar disorder remain scarce and contested. The introduction summarises prior case-based observations (including an earlier case by the author of a teenager whose suicidality and complex PTSD improved after unsupervised LSD and low‑dose DMT sessions), outlines theoretical mechanisms by which psychedelics might act in trauma‑related illness (for example, by re‑evoking dissociated early traumatic material or acting as an 'anti‑dissociative'), and reviews key pharmacological and safety considerations for ayahuasca (MAOI components plus DMT), including known drug interaction risks and the low reported incidence of acute psychotic presentations in organised ritual contexts. M. and colleagues frame the present paper as a retrospective single‑case study that aims to contribute to understanding how ayahuasca may affect a complex clinical picture comprising long‑standing childhood sexual abuse, dissociation, suicidality and diagnoses given by clinicians (bipolar disorder and borderline personality disorder) but initially rejected by the patient. The study reports on the patient's experience across multiple group ayahuasca ceremonies, documents clinical and personal outcomes over several years including follow‑up interviews, and situates the case in the context of alternative dosing strategies (notably a low‑dose maintenance approach described by a practitioner named Mudge) and other published case reports of psychedelic effects in affective and psychotic conditions.
Expert Research Summaries
Go Pro to access AI-powered section-by-section summaries, editorial takes, and the full research toolkit.
Full Text PDF
Full Paper PDF
Pro members can view the original manuscript directly in the browser.
Study Details
- Study Typeindividual
- Journal
- Compounds
- Topics
- APA Citation
Turkia, M. (2023). Ayahuasca in the treatment of bipolar disorder with psychotic features-A retrospective case study. https://doi.org/10.31234/osf.io/65se9
References (33)
Papers cited by this study that are also in Blossom
Van Amsterdam, J., Opperhuizen, A., Van Den Brink, W. · Regulatory Toxicology and Pharmacology (2011)
Bouso, J. C., Andión, O., Sarris, J. et al. · PLOS Global Public Health (2022)
Brennan, W., Jackson, M. A., MacLean, K. A. · Journal of Humanistic Psychology (2021)
Callon, C., Williams, M., Lafrance, A. · Journal of Humanistic Psychology (2021)
Carhart-Harris, R. L., Erritzoe, D., Williams, T. et al. · PNAS (2012)
Pontual, A. A. D. D., Tófoli, L. F., Corradi-Webster, C. M. et al. · Frontiers in Psychology (2022)
Devenot, N., Seale-Feldman, A., Smith, E. et al. · Kennedy Institute of Ethics Journal (2022)
Dourron, H. M., Strauss, C., Hendricks, P. S. · Pharmacological Reviews (2022)
Flanagan, T. W., Nichols, C. D. · International Review of Psychiatry (2018)
Frecska, E., Bokor, P., Winkelman, M. J. · Frontiers in Pharmacology (2016)
Show all 33 referencesShow fewer
González, D., Cantillo, J., Perez, I. et al. · Frontiers in Pharmacology (2021)
Haden, M., Woods, B. · Journal of Studies on Alcohol and Drugs (2020)
Hartogsohn, I. · Frontiers in Pharmacology (2021)
Hendricks, P. S. · International Review of Psychiatry (2018)
Henríquez-Hernández, L. A., Rojas-Hernández, J., Quintana-Hernández, D. J. et al. · Toxics (2023)
Kettner, H., Rosas, F. E., Timmermann, C. et al. · Frontiers in Pharmacology (2021)
Malcolm, B., Thomas, K. · Psychopharmacology (2021)
Nayak, S., Gukasyan, N., Barrett, F. S. et al. · Pharmacopsychiatry (2021)
Oehen, P., Gasser, P. · Frontiers in Psychiatry (2022)
Ona, G., Berrada, A., Bouso, J. C. · Transcultural Psychiatry (2021)
Palhano-Fontes, F., Barreto, D., Onias, H. et al. · Psychological Medicine (2018)
Passie, T., Guss, J., Kraehenmann, R. · Frontiers in Psychiatry (2022)
Perkins, D., Pagni, B. A., Sarris, J. et al. · Frontiers in Pharmacology (2022)
Perkins, D., Ruffell, S. G. D., day, K. et al. · Frontiers in Neuroscience (2023)
Preller, K. H., Burt, J. B., Adkinson, B. et al. · eLife (2018)
Reckweg, J., Uthaug, M. V., Szabo, A. et al. · Journal of Neurochemistry (2022)
Ruffell, S. G. D., Netzband, N., Tsang, W. et al. · Frontiers in Psychiatry (2021)
Dos Santos, R. G., Hallak, J. E., Bouso, J. C. · Therapeutic Advances in Psychopharmacology (2017)
Dos Santos, R. G., Osório, F. L., Crippa, J. A. et al. · brazilian Journal of Psychiatry (2016)
Sessa, B., Fischer, F. M. · Drug Science Policy and Law (2015)
Sottile, R. J., Vida, T. · Frontiers in Psychiatry (2022)
Szmulewicz, A. G., Valerio, M. P., Smith, J. M. · International Journal of Bipolar Disorders (2015)
Turkia, M. · Psychiatry Research (2022)
Your Personal Research Library
Go Pro to save papers, add notes, rate studies, and organize your research into custom shelves.